Cargando…

Analysis of oncogenic AKT1 p.E17K mutation in carcinomas of the biliary tract and liver

Detalles Bibliográficos
Autores principales:	Riener, M-O, Bawohl, M, Clavien, P-A, Jochum, W
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2008
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528140/ https://www.ncbi.nlm.nih.gov/pubmed/18728674 http://dx.doi.org/10.1038/sj.bjc.6604498

Ejemplares similares

Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias
por: Kim, M S, et al.
Publicado: (2008)

Mutant AKT1-E17K is oncogenic in lung epithelial cells
por: De Marco, Carmela, et al.
Publicado: (2015)

Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis
por: Mancini, Maria L., et al.
Publicado: (2016)

AKT1(E17K) mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection
por: Rudolph, Marion, et al.
Publicado: (2016)

AKT1(E17K) Is Oncogenic in Mouse Lung and Cooperates with Chemical Carcinogens in Inducing Lung Cancer
por: Malanga, Donatella, et al.
Publicado: (2016)

Hepatitis E Virus Detection in Liver Tissue from Patients with Suspected Drug-Induced Liver Injury
por: Chijioke, Obinna, et al.
Publicado: (2015)

Diseases of the liver and biliary tract /
Publicado: (1992)

Diseases of the Liver and Biliary Tract
por: Johnson, Susan E., et al.
Publicado: (2006)

E17K substitution in AKT1 in prostate cancer
por: Boormans, J L, et al.
Publicado: (2010)

Effect of AKT1 (p. E17K) Hotspot Mutation on Malignant Tumorigenesis and Prognosis
por: Chen, Ying, et al.
Publicado: (2020)

K‐Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines
por: Yeung, Yvonne, et al.
Publicado: (2017)

Prediction of a highly deleterious mutation E17K in AKT-1 gene: An in silico approach
por: Khan, Imran, et al.
Publicado: (2017)

Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092
por: Yu, Yi, et al.
Publicado: (2015)

Primary Carcinomas of the Liver and Biliary Tract
por: Shanmugaratnam, K.
Publicado: (1956)

The Liver, Biliary Tract, and Exocrine Pancreas
por: Center, Sharon A.
Publicado: (2011)

Inflammatory Diseases of the Liver and Biliary Tract
Publicado: (2007)

The transforming mutation E17K/AKT1 is not a major event in B-cell-derived lymphoid leukaemias
por: Mahmoud, I S, et al.
Publicado: (2008)

Oncogenic KRAS–expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice
por: Kasuga, Akiyoshi, et al.
Publicado: (2021)

Atypical progeroid syndrome (p.E262K LMNA mutation): a rare cause of short stature and osteoporosis
por: Yukina, Marina, et al.
Publicado: (2021)

Liver Fluke-Associated Biliary Tract Cancer
por: Prueksapanich, Piyapan, et al.
Publicado: (2018)

Accurate detection of low prevalence AKT1 E17K mutation in tissue or plasma from advanced cancer patients
por: de Bruin, Elza C., et al.
Publicado: (2017)

Molecular profile of BRCA-mutated biliary tract cancers
por: Spizzo, Gilbert, et al.
Publicado: (2020)

The AKT1E17K Allele Promotes Breast Cancer in Mice
por: Malanga, Donatella, et al.
Publicado: (2022)

Liver cancer with concomitant TP53 and CTNNB1 mutations: a case report
por: Friemel, Juliane, et al.
Publicado: (2016)

The peu‐miR160a−PeARF17.1/PeARF17.2 module participates in the adventitious root development of poplar
por: Liu, Sian, et al.
Publicado: (2019)

Mutational spectrum and precision oncology for biliary tract carcinoma
por: Lin, Jianzhen, et al.
Publicado: (2021)

Detection of the transforming AKT1 mutation E17K in non-small cell lung cancer by high resolution melting
por: Do, Hongdo, et al.
Publicado: (2008)

Cancer Associated E17K Mutation Causes Rapid Conformational Drift in AKT1 Pleckstrin Homology (PH) Domain
por: Kumar, Ambuj, et al.
Publicado: (2013)

Protein-targeting strategy used to develop a selective inhibitor of the E17K point mutation in the PH Domain of Akt1
por: Deyle, Kaycie M., et al.
Publicado: (2015)

A novel p.E276K IDUA mutation decreasing α-L-iduronidase activity causes mucopolysaccharidosis type I
por: Prommajan, Korrakot, et al.
Publicado: (2011)

The mutation p.E113K in the Schiff base counterion of rhodopsin is associated with two distinct retinal phenotypes within the same family
por: Reiff, Charlotte, et al.
Publicado: (2016)

Ki-ras point mutations and proliferation activity in biliary tract carcinomas.
por: Ohashi, K., et al.
Publicado: (1996)

Recognition of nuclear export signals by CRM1 carrying the oncogenic E571K mutation
por: Baumhardt, Jordan M., et al.
Publicado: (2020)

Correction: Molecular profile of BRCA-mutated biliary tract cancers
Publicado: (2020)

P.E. (civil) license review manual /
Publicado: (1990)

Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas
por: Chow, W H, et al.
Publicado: (1999)

Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer
por: Aleksandrova, Krasimira, et al.
Publicado: (2014)

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
por: Brastianos, Priscilla K., et al.
Publicado: (2013)

Pulmonary valve papillary fibroelastoma: to PE or not to PE
por: Kirk, Frazer, et al.
Publicado: (2023)

Targeting AKT-Dependent Regulation of Antioxidant Defense Sensitizes AKT-E17K Expressing Cancer Cells to Ionizing Radiation
por: Goetting, Isabell, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ogcln93ivhle1ouumtdga89g04